These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6070701)

  • 21. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility.
    Romans DG; Tilley CA; Dorrington KJ
    J Immunol; 1980 Jun; 124(6):2807-11. PubMed ID: 7189535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of functional assays for evaluation of immune red cell destruction and their clinical application].
    Zupańska B
    Acta Haematol Pol; 1994; 25(4):289-96. PubMed ID: 7847029
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnostic and prognostic significance of erythrocyte adenosine triphosphatase activity changes in hemolytic disease in the newborn].
    Osipov AI
    Vopr Okhr Materin Det; 1969 Feb; 14(2):90. PubMed ID: 4241957
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jr.
    Arriaga F; Gomez I; Linares MD; Gascon A; Carpio N; Perales A
    Transfusion; 2009 Apr; 49(4):813. PubMed ID: 19335378
    [No Abstract]   [Full Text] [Related]  

  • 25. The benefit of the direct antiglobulin test using gel technique in ABO hemolytic disease of the newborn.
    Chuansumrit A; Siripoonya P; Nathalang O; Sriphaisal T
    Southeast Asian J Trop Med Public Health; 1997 Jun; 28(2):428-31. PubMed ID: 9444034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance and clinico-experimental value of the methods of study of hemolytic disease of the newborn. II. Labeling of blood group antibodies with fluorescein isothiocyanate].
    Spoto P; Campa M; Palagi R; Senesi S
    Minerva Ginecol; 1970 May; 22(10):496-9. PubMed ID: 4929592
    [No Abstract]   [Full Text] [Related]  

  • 27. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erythrocyte acetylcholinesterase activity in newborn infants with hemolytic disease due to ABO incompatibility].
    Sbraccia C; Carapella de Luca E; Bonanni V
    Minerva Pediatr; 1965 Oct; 17(29):1527-31. PubMed ID: 5892925
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
    Kumlien G; Sarman I; Shanwell A
    Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 31. [ABO materno-fetal incompatibility in the newborn infant: clinical usefulness of Coombs test and elution for the study of hemolytic disease].
    Fernández MP; Silva JJ; Toledo M; Orrego E; Rodríguez C
    Rev Med Chil; 1991 Dec; 119(12):1414-8. PubMed ID: 9723099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-c antibody neonatal hemolytic disease: a case report].
    Colombo P; Bianchi GA; Mariani F; Corbetta MG
    Minerva Pediatr; 1996 Apr; 48(4):149-53. PubMed ID: 8766965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serological specificity of the sensitising antibodies in ABO heterospecific pregnancy of the group O mother.
    Voak D
    Vox Sang; 1968; 14(4):271-81. PubMed ID: 5690209
    [No Abstract]   [Full Text] [Related]  

  • 34. [A direct serum-gelatin test for hemolytic disease of the newborn].
    Konstantinova TA
    Probl Gematol Pereliv Krovi; 1971; 16(4):61-2. PubMed ID: 5166032
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prenatal prognosis of hemolytic disease of newborn. II. Prognosits value of maternal antibodies].
    POLACEK K
    Cesk Gynekol; 1961 Apr; 26():212-9. PubMed ID: 13736656
    [No Abstract]   [Full Text] [Related]  

  • 36. A fluorimetric enzyme-linked immunoassay (FEIA) for measurement of anti-D antibodies.
    Parinaud J; Blanc M; Fournié A; Biermé S; Grandjean H
    Nouv Rev Fr Hematol (1978); 1984; 26(5):299-302. PubMed ID: 6438605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic disease of the newborn caused by anti-JK3.
    Goldman H; Levinsky D
    Obstet Gynecol; 1982 Oct; 60(4):526-8. PubMed ID: 7121941
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the detection of hemolytic disease of the newborn].
    Brüster H
    Kinderarztl Prax; 1965 Nov; 33(11):505-6. PubMed ID: 5894961
    [No Abstract]   [Full Text] [Related]  

  • 39. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 40. Severity of hemolytic disease of the newborn.
    Bornstein MS
    Obstet Gynecol; 1971 Jan; 37(1):159. PubMed ID: 5099602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.